Pierre Mordant
Overview
Explore the profile of Pierre Mordant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
1091
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Veith I, Nurmik M, Mencattini A, Damei I, Lansche C, Brosseau S, et al.
Cell Rep Med
. 2024 May;
5(5):101549.
PMID: 38703767
There is a compelling need for approaches to predict the efficacy of immunotherapy drugs. Tumor-on-chip technology exploits microfluidics to generate 3D cell co-cultures embedded in hydrogels that recapitulate simplified tumor...
12.
Sayadi A, Debray M, Mordant P, Dupin C, Guyard A
Am J Respir Crit Care Med
. 2024 Mar;
209(10):1258-1260.
PMID: 38530087
No abstract available.
13.
Betser L, Le Bras A, Etienne H, Roussel A, Bobbio A, Al-Zreibi C, et al.
J Robot Surg
. 2024 Mar;
18(1):124.
PMID: 38492119
Robotic-assisted thoracic surgery (RATS) is an effective treatment of non-small cell lung cancer (NSCLC) but the effects of its implementation in university hospital networks has not been described. We analyzed...
14.
Messika J, Eloy P, Boulate D, Charvet A, Fessler J, Jougon J, et al.
BMJ Open
. 2024 Mar;
14(3):e077770.
PMID: 38448059
Introduction: Lung transplantation (LTx) aims at improving survival and quality of life for patients with end-stage lung diseases. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used as intraoperative support for LTx,...
15.
Etienne H, Pages P, Iquille J, Falcoz P, Brouchet L, Berthet J, et al.
ERJ Open Res
. 2024 Jan;
10(1).
PMID: 38259816
Introduction: Non-small cell lung cancer (NSCLC) is often associated with compromised lung function. Real-world data on the impact of surgical approach in NSCLC patients with compromised lung function are still...
16.
Moncomble E, Weisenburger G, Picard C, Degot T, Reynaud-Gaubert M, Nieves A, et al.
Respirology
. 2023 Oct;
29(1):71-79.
PMID: 37789612
Background: Antifibrotic agents (AFAs) are now standard-of-care for idiopathic pulmonary fibrosis (IPF). Concerns have arisen about the safety of these drugs in patients undergoing lung transplantation (LTx). Methods: We performed...
17.
Brockaert T, Ferreira I, Laplante A, Fogel P, Grimbert D, Mordant P
J Clin Med
. 2023 Sep;
12(18).
PMID: 37762988
Background: Peripheral femoro-femoral veno-arterial extracorporeal membrane oxygenation is increasingly used in refractory cardiogenic shock. However, the obstruction of the femoral artery by the return cannula could lead to acute limb...
18.
Combet M, Mouren D, Motiejunaite J, Bunel V, Mordant P, Castier Y, et al.
Respir Med Res
. 2023 Aug;
84:101041.
PMID: 37625376
No abstract available.
19.
Marchal-Duval E, Homps-Legrand M, Froidure A, Jaillet M, Ghanem M, Lou D, et al.
Elife
. 2023 Jun;
12.
PMID: 37261432
Matrix remodeling is a salient feature of idiopathic pulmonary fibrosis (IPF). Targeting cells driving matrix remodeling could be a promising avenue for IPF treatment. Analysis of transcriptomic database identified the...
20.
Dieudonne Y, Silvestrini M, Dossier A, Meignin V, Jouenne F, Mahevas T, et al.
Br J Haematol
. 2023 May;
202(2):267-278.
PMID: 37221131
Unicentric Castleman disease (UCD) is a lymphoproliferative disease of unknown cause. Paraneoplastic pemphigus (PNP) is a major complication shown to be associated with a poor prognosis, with particular severity in...